SSKN — STRATA Skin Sciences Share Price
Last trade - 00:00- $10.76m
- $20.60m
- $33.36m
- 28
- 67
- 15
- 30
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.17 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.34 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -35.75% | ||
| Return on Equity | -79.04% | ||
| Operating Margin | -30.16% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 31.59 | 23.09 | 29.98 | 36.16 | 33.36 | 31.16 | 33.81 | 2.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Directors
- Uri Geiger NEC (53)
- Robert Moccia PRE (62)
- Christopher Lesovitz CFO
- William Humphries IND (55)
- Samuel Navarro IND (65)
- Samuel Rubinstein IND (80)
- Nachum Shamir IND (67)
- Douglas Strang IND
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- September 3rd, 1997
- Public Since
- October 28th, 2005
- No. of Employees
- 99
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 3,506,092
- Address
- 5 Walnut Grove Dr Ste 140, HORSHAM, 19044-2252
- Web
- http://www.strataskinsciences.com/
- Phone
- +1 2156193200
- Contact
- Rich Cockrell
- Auditors
- Marcum LLP
Latest News for SSKN
Upcoming Events for SSKN
Q2 2024 STRATA Skin Sciences Inc Earnings Release
STRATA Skin Sciences Inc Annual Shareholders Meeting
Q3 2024 STRATA Skin Sciences Inc Earnings Release
Similar to SSKN
Accelerate Diagnostics
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Agendia NV
NASDAQ Capital Market
FAQ
As of Today at 23:30 UTC, shares in STRATA Skin Sciences are trading at $3.15. This share price information is delayed by 15 minutes.
Shares in STRATA Skin Sciences last closed at $3.15 and the price had moved by -65.38% over the past 365 days. In terms of relative price strength the STRATA Skin Sciences share price has underperformed the S&P500 Index by -72.46% over the past year.
The overall consensus recommendation for STRATA Skin Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
STRATA Skin Sciences does not currently pay a dividend.
STRATA Skin Sciences does not currently pay a dividend.
STRATA Skin Sciences does not currently pay a dividend.
To buy shares in STRATA Skin Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $3.15, shares in STRATA Skin Sciences had a market capitalisation of $11.04m.
Here are the trading details for STRATA Skin Sciences:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SSKN
Based on an overall assessment of its quality, value and momentum STRATA Skin Sciences is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in STRATA Skin Sciences is $26.00. That is 725.4% above the last closing price of $3.15.
Analysts covering STRATA Skin Sciences currently have a consensus Earnings Per Share (EPS) forecast of -$2.80 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like STRATA Skin Sciences. Over the past six months, its share price has underperformed the S&P500 Index by -51.03%.
As of the last closing price of $3.15, shares in STRATA Skin Sciences were trading -37.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The STRATA Skin Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
STRATA Skin Sciences' management team is headed by:
- Uri Geiger - NEC
- Robert Moccia - PRE
- Christopher Lesovitz - CFO
- William Humphries - IND
- Samuel Navarro - IND
- Samuel Rubinstein - IND
- Nachum Shamir - IND
- Douglas Strang - IND